Status:
COMPLETED
Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation
Lead Sponsor:
Peking University People's Hospital
Conditions:
Haploidentical Hematopoietic Stem Cell Transplantation
Eligibility:
All Genders
15-60 years
Phase:
PHASE2
Brief Summary
The aim of the study is to evaluate the efficacy of the prophylactic administration of N-acetyl-L-cysteine (NAC) in acute leukemia patients with complete remission pre- and post-allotransplant on the ...
Detailed Description
Acute leukemia patients with complete remission, whose bone marrow endothelial cells were less than 0.1% detected before haploidentical hematopoietic stem cell transplantation, receive NAC (orally at ...
Eligibility Criteria
Inclusion
- Acute leukemia patients with complete remission, whose bone marrow endothelial cells were less than 0.1% detected before haploidentical hematopoietic stem cell transplantation；
Exclusion
- Bronchial asthma;
- Allergic to N-acetyl-L-cystein
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03236220
Start Date
August 1 2017
End Date
December 1 2018
Last Update
September 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijng, China